Fc gamma RIIIA / CD16a

Fc gamma RIIIA / CD16a

Fc gamma RIIIA / CD16a 분자 정보

Molecule Name
Low affinity immunoglobulin gamma Fc region receptor III-A
분자 별명
FCGR3A,CD16A,FCG3,FCGR3,IGFR3
Drug Development Progress
임상 약물 수14
시판 약물 수0
최고 연구 개발 단계Phase 2 Clinical
표적 별명
IGFR3,FCG3,Fc Fragment Of IgG, Low Affinity IIIa, Receptor For (CD16),Fc Fragment Of IgG, Low Affinity III, Receptor For (CD16),Immunoglobulin G Fc Receptor III,Fc-Gamma Receptor III-2 (CD 16),Neutrophil-Specific Antigen NA,Fc-Gamma Receptor IIIb (CD16),Fc Gamma Receptor III-A,Low Affinity Immunoglobulin Gamma Receptor III-A Fc Fragment,IgG Fc receptor III-2,Low affinity immunoglobulin gamma Fc region receptor III-A,FCGR3,CD16A,Fc-gamma RIII-alpha,FCGR3A,Fc Fragment Of IgG Receptor IIIa,Fc Fragment Of IgG, Low Affinity IIIa, Receptor (CD16a),CD16a Antigen,Fc Gamma Receptor IIIa,Fc-Gamma RIIIa,Fc-Gamma RIII,FcgammaRIIIA,FCGRIII,FcRIIIa,FCR-10,FCRIII,IMD20,CD16
분자 배경
CD16 is a low affinity Fc receptor, and has been identified as Fc receptors FcγRIIIa (CD16a) and FcγRIIIb (CD16b). These receptors bind to the Fc portion of IgG antibodies. CD16 encoded by two different highly homologous genes in a cell type-specific manner.CD16 is found on the surface of natural killer cells, neutrophil polymorphonuclear leukocytes, monocytes and macrophages. CD16a antigen is also known as Low affinity immunoglobulin gamma Fc region receptor III-A, Fc-gamma RIII-alpha. CD16b is a low-affinity, GPI-linked receptor expressed by neutrophils and eosinophils, whereas CD16a is an intermediate affinity polypeptide-anchored transmembrane glycoprotein expressed natural killer cells, macrophages, subpopulation of T-cells, immature thymocytes and placentaltrophoblasts.CD16a is involved in phagocytosis, secretion of enzymes and inflammatory mediators, antibody­dependent cytotoxicity and clearance of immune complexes. Aberrant expression or mutations of CD16a is implicated in susceptibility to recurrent viral infections, systemic lupus erythematosus, and alloimmune neonatal neutropenia.

Fc gamma RIIIA / CD16a 제품 목록

Species
  • Human(7)
Tag
  • His Tag(3)
  • His Tag & Avi Tag(2)
  • His Tag & HSA Tag(1)
  • His Tag & SUMO Tag(1)
Host
  • HEK293(7)
Conjugate
  • Unconjugated(5)
  • Biotin-labeled(2)
Grade
  • RUO(7)
Low Endotoxin
  • No(7)
You Have Viewed 1-7 Of 7 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity

항체 프로젝트 거래 플랫폼

프로젝트 이름프로젝트 단계분자 유형분자 출처질병 영역적응증
CD16a VHH - 01PCCMonoclonalNanobodySolid TumorSolid tumor,Hematoma
프로젝트 이름
CD16a VHH - 01
프로젝트 단계
PCC
분자 유형
Monoclonal
분자 출처
Nanobody
질병 영역
Solid Tumor
적응증
Solid tumor,Hematoma
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
AcimtamigAFM-13Phase 2 ClinicalThe University Of Texas MD Anderson Cancer Center
Hodgkin Disease; Lymphoma, B-Cell; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Mycosis Fungoides
상세
IPH-6501IPH-6501; IPH-65Phase 2 ClinicalInnate Pharma SA
Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neoplasms
상세
FT-538FT-538Phase 2 ClinicalFate Therapeutics Inc
Coronavirus Disease 2019 (COVID-19); Fallopian Tube Neoplasms; HIV Infections; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Respiratory Distress Syndrome, Adult; Solid tumours
상세
GMA-161GMA-161Phase 1 ClinicalMacrogenics Inc, Sanofi
Purpura, Thrombocytopenic, Idiopathic
상세
GTB-5550GTB-5550; B7H3 TriKE™; cam1615B7H3; GTB-5550 TriKE™Phase 1 ClinicalUniversity Of Minnesota
Solid tumours
상세
FT-576FT-576Phase 1 ClinicalFate Therapeutics Inc, University Of Minnesota
Bone Marrow Neoplasms; Multiple Myeloma
상세
AFM-28AFM-28Phase 1 ClinicalAffimed
Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Neoplasms
상세
Donor-derived CD123-CD16 bispecific antibody-modified NK cells therapy(Chinese PLA General Hospital)Phase 1 ClinicalPla General Hospital
Leukemia, Myeloid, Acute
상세
GTB-3650GTB-3650; GTB-360; OXS-3350; OXS-C3550Phase 1 ClinicalMasonic Cancer Center, University Of Minnesota
Bone Marrow Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
상세
BGB-B3227BGB-B3227Phase 1 ClinicalBeOne Medicines (Beijing) Co Ltd
Gastrointestinal Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Neoplasms; Solid tumours
상세
SM-3321SM-3321; SM3321Phase 1 ClinicalZhuhai StarMab BioMed Technology Ltd
Leukemia, Myeloid, Acute; Neoplasms
상세
FT-596FT-596Phase 1 ClinicalFate Therapeutics Inc
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin
상세
SAR-443579SAR-443579; SAR443579; SAR'579; IPH6101; IPH-6101Phase 1 ClinicalSanofi
Blastic Plasmacytoid Dendritic Cell Neoplasm; Hematologic Diseases; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma
상세
FT-516FT-516Phase 1 ClinicalFate Therapeutics Inc, University Of Minnesota
Abdominal Neoplasms; Coronavirus Disease 2019 (COVID-19); Fallopian Tube Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Ovarian Neoplasms; Solid tumours
상세
Customer Reviews
  • A***n2025-02-12
    Acro's Fc gamma receptor proteins are my top choice for Octet binding assays. They consistently deliver reliable results, crucial for accurate research. Their product quality is outstanding, ensuring reproducible experiments. Acro's technical service is exceptional, with a responsive and knowledgeable support team. Their comprehensive range of well-characterized Fc receptor proteins, high purity, and bioactivity have made them my exclusive supplier. The attention to quality control ensures excellent batch-to-batch consistency.
  • W***u2024-10-08
    We used this biotin labeled protein in the ELISA assay and we have got reproducible and high-quality results. Also I want to mention and there is no degradation or activity changes of this product over more than half year, which made it our experiment easier without bridging assay.
  • J***n2023-06-24
    We used the biotinylated human Fc gamma RIIIA material from Acro to test the binding of different human antibodies. The material arrived quickly and in time for our experiments. I used the material with the Biacore 8K (SPR) instrument using Series S Biotin CAP chip. We were happy with how the material worked in this assay format. Overall, we were pleased with the quality and would recommend this to other researchers.
  • D***g2022-12-07
    I have been using this product for screening antibody binding. The product showed satisfactory binding to streptavidin-coated beads, as well as satisfactory detection of an antibody control. I have also used a range of other biotinylated Fc gamma receptor products from Acro, which showed good binding to respective control antibodies, as well as stability at 4C when reconstituted (no compromised antibody binding results in a month).
  • 1***62019-10-16
    We purchased several Fc receptor proteins. Our purpose is to test the binding affinity between antibodies and Fc receptors using Fortebio. Compared with products from other vendors, Acro's products have a higher purity and better bioactivity. Besides, their delivery is really fast. Looking forward to buying more products from ACRO in the future!